Decrease of nitric oxide end-products during coronary circulation reflects elevated basal coronary artery tone in patients with vasospastic angina

Japanese Heart Journal

Volumn 41, Issue 5, 2000, Pages 583-595

  Hori, Tomoyuki ^a   Matsubara, Taku ^a   Ishibashi, Takaharu ^b   Yamazoe, Masaru ^a   Ida, Toru ^a   Higuchi, Kotaro ^a   Takemoto, Minoru ^a   Ochiai, Sachie ^a   Tamura, Yusuke ^a   Aizawa, Yoshifusa ^a   Nishio, Matomo ^b  

^a NIIGATA UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Coronary circulation; Ergonovine maleate; Nitric oxide; Vasospasm

Indexed keywords

ERGOMETRINE MALEATE; NITRATE; NITRIC OXIDE; NITRITE;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTERY TONE; ARTICLE; BLOOD LEVEL; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY SPASM; CORONARY SINUS; CORONARY VEIN; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS;

EID: 0033634949     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/jhj.41.583     Document Type: Article

References (35)

1. Endothelial modulation of coronary tone
2. Endothelial control of vascular tone in large and small coronary arteries
3. The L-arginine-nitric oxide pathway
4. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
5. Vascular endothelial cells synthesize nitric oxide from L-arginine
6. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs
7. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
8. Effects of inhibition of nitric oxide synthesis on epicardial artery caliber and coronary blood flow in humans
9. Nitric oxide activity in the human coronary circulation impact of risk factors for coronary atherosclerosis
10. Bradykinin-induced vasodilation is impaired at the atherosclerotic site but is preserved at the spastic site of human coronary artery in vivo
11. Regional coronary artery dilation response in variant angina
12. Correlation of basal coronary artery tone with constrictive response to ergonovine in patients with variant angina
13. Significance of coronary artery tone in patients with variant angina
14. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina
15. Basal release of endothelium-derived mine oxide at site of spasm in patients with variant angina
16. Correlation between arteriographic and electrocardiographic features during spasm in the left anterior descending coronary artery
17. Effect of direct intracoronary administration of methylergonovine in patients with and without variant angina
18. Cyclic GMP elevation by 5-hydroxytryptamine is due to nitric oxide derived from endogenous nitrosothiol in NG 108-15 cells
19. Simultaneous measurement of nitrite and nitrate levels as indices of nitric oxide release in the cerebellum of conscious rats
20. - difference in human coronary circulation with severe atherosclerotic stenosis
21. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxode formation in conscious dogs
22. Metabolism and excretion of nitric oxide in humans
23. Increased release of nitric oxide in ischemic hearts after exercise in patients with effort angina
24. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina
25. Vitamin E deficiency in variant angina
26. Nitric oxide, superoxide, and peroxynitrite the good, the bad and the ugly
27. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide
28. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins
29. Impairment of endothelium-dependent dilation in rabbits renal arteries by oxidized lipoprotein (a). Role of oxygen-derived radicals
30. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog
31. Coronary arterial spasm in ischemic heart disease and its pathogenesis
32. Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin
33. Supersensitive dilator response to nitroglycerin but not to atrial natriuretic peptide in spastic coronary arteries in coronary spastic angina
34. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris
35. Response of the coronary artery to a small dose of ergonovine in variant angina